Menu
Menu
VOSEVI is a fixed-dose combination tablet containing sofosbuvir, velpatasvir, and voxilaprevir for oral administration. If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.
VOSEVI is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1, 2, 3, 4, 5, or 6 infection with or without cirrhosis (compensated) who have previously been treated with a Hep C regimen containing an NS5A inhibitor.
VOSEVI (Sofosbuvir) Tablets suppliers in India. Allevaire India New Delhi, INDIA.
Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.
SOURCING:
Alleviare Life Sciences connects the buyer with the supplier who can ship VOSEVI (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. Panimun Bioral (Cyclosporine) is manufactured by Panacea Biotec.
Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
The order for VOSEVI (Sofosbuvir) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
VOSEVI is a fixed-dose combination of sofosbuvir, a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor, velpatasvir, an HCV NS5A inhibitor, and voxilaprevir, an HCV NS3/4A protease inhibitor, and is indicated for the treatment of adult patients with chronic HCV infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have (1, 2.2, 14):
Genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an HCV regimen containing an NS5A inhibitor.
Genotype 1a or 3 infection and have previously been treated with an HCV regimen containing sofosbuvir without an NS5A inhibitor.
Additional benefit of VOSEVI over sofosbuvir/velpatasvir was not shown in adults with genotype 1b, 2, 4, 5, or 6 infection previously treated with sofosbuvir without an NS5A inhibitor.
Medicine Name: Vosevi
Generic Name: Sofosbuvir
Approval Date: July 18, 2017
Company Name: Gilead Sciences, Inc.
Available as (Form & Strength): Tablets: 400 mg sofosbuvir, 100 mg velpatasvir, and 100 mg voxilaprevir.
VOSEVI (Sofosbuvir) is available.
Get In Touch
ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand VOSEVI (Sofosbuvir) Tablets on prescription and Import License in Patient’s Name only.
For foreign countries patients, VOSEVI (Sofosbuvir) Tablets can be made available in Send your inquiry to find VOSEVI (Sofosbuvir) Tablets in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For VOSEVI (Sofosbuvir) Tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Visit Us:
MEZZANINE FLOOR, S-9, GREEN PARK EXTENSION, New Delhi,
South Delhi, Delhi, 110016
Call Us:
+91-9818274099
Write Us:
kamal@alleviarelife.com
